Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $497.80 | 21 | 98.5% |
| Education | $7.68 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pulmonx Corporation | $159.08 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $121.47 | 8 | $0 (2022) |
| GlaxoSmithKline, LLC. | $62.80 | 4 | $0 (2022) |
| Grifols USA, LLC | $39.49 | 2 | $0 (2022) |
| Advanced Respiratory, Inc | $34.25 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.97 | 2 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $22.58 | 1 | $0 (2023) |
| Philips Electronics North America Corporation | $18.53 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $17.31 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $22.58 | 1 | Teva Pharmaceuticals USA, Inc. ($22.58) |
| 2022 | $385.54 | 16 | Pulmonx Corporation ($159.08) |
| 2021 | $97.36 | 5 | Advanced Respiratory, Inc ($34.25) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Central Nervous System | ||||||
| 10/05/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.32 | General |
| 08/31/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2022 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: PULMONOLOGY | ||||||
| 08/10/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Respiratory | ||||||
| 07/13/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Respiratory | ||||||
| 07/06/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Pulmonology | ||||||
| 06/08/2022 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $149.00 | General |
| Category: PULMONOLOGY | ||||||
| 06/08/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Respiratory | ||||||
| 06/08/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Education | In-kind items and services | $7.68 | General |
| Category: Respiratory | ||||||
| 05/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: RESPIRATORY | ||||||
| 04/27/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological), TEZSPIRE | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: Respiratory | ||||||
| 04/26/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: RESPIRATORY | ||||||
| 04/20/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Pulmonology | ||||||
| 04/13/2022 | Philips Electronics North America Corporation | (8685) OEM Other (Device) | Food and Beverage | Cash or cash equivalent | $18.53 | General |
| Category: Medical Device | ||||||
| 04/01/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 01/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: COVID-19 | ||||||
| 07/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: RESPIRATORY | ||||||
| 07/13/2021 | Advanced Respiratory, Inc | The Vest System 205 Acute Care (Device), The MetaNeb System, The Monarch Airway Clearance System | Food and Beverage | In-kind items and services | $34.25 | General |
| Category: Airway Clearance Device | ||||||
| 07/13/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Respiratory | ||||||
| 06/29/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 525 | 811 | $208,764 | $61,837 |
| 2022 | 8 | 418 | 694 | $204,686 | $60,430 |
| 2021 | 9 | 267 | 547 | $167,805 | $47,110 |
| 2020 | 10 | 372 | 824 | $191,066 | $56,658 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 312 | $53,664 | $18,918 | 35.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 76 | 89 | $43,788 | $11,614 | 26.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 36 | 69 | $45,333 | $10,811 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $25,740 | $7,887 | 30.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 109 | $19,075 | $6,414 | 33.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 32 | $8,096 | $2,802 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $6,630 | $1,771 | 26.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 15 | 15 | $2,625 | $922.35 | 35.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 91 | 93 | $3,813 | $696.87 | 18.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 44 | 116 | $76,212 | $19,364 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 179 | $30,788 | $11,466 | 37.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 74 | $36,408 | $11,208 | 30.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 113 | $19,775 | $6,204 | 31.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 66 | $16,698 | $5,228 | 31.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 70 | 70 | $17,850 | $5,101 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,290 | $1,384 | 32.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 65 | 65 | $2,665 | $474.56 | 17.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 60 | 245 | $50,095 | $13,850 | 27.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 11 | 67 | $44,019 | $11,359 | 25.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 56 | 62 | $33,663 | $9,654 | 28.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 44 | $12,746 | $3,622 | 28.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 43 | 43 | $10,965 | $3,489 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 37 | $6,364 | $2,550 | 40.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $5,070 | $1,453 | 28.7% |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 2021 | 11 | 12 | $3,898 | $939.36 | 24.1% |
About Dr. Gregory Pfister, M.D
Dr. Gregory Pfister, M.D is a Internal Medicine healthcare provider based in Shelbyville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2010. The National Provider Identifier (NPI) number assigned to this provider is 1306161575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Pfister, M.D has received a total of $505.48 in payments from pharmaceutical and medical device companies, with $22.58 received in 2023. These payments were reported across 22 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($497.80).
As a Medicare-enrolled provider, Pfister has provided services to 1,582 Medicare beneficiaries, totaling 2,876 services with total Medicare billing of $226,035. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Shelbyville, KY
- Active Since 03/31/2010
- Last Updated 05/12/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1306161575
Products in Payments
- CHARTIS CATHETER (Device) $159.08
- TRELEGY ELLIPTA (Drug) $62.80
- BREZTRI (Drug) $53.34
- Prolastin-C Liquid (Biological) $39.49
- The Vest System 205 Acute Care (Device) $34.25
- FASENRA (Biological) $32.95
- Austedo XR (Drug) $22.58
- TEZSPIRE (Biological) $20.86
- (8685) OEM Other (Device) $18.53
- Veklury (Drug) $17.31
- STIOLTO RESPIMAT (Drug) $16.53
- SPIRIVA RESPIMAT (Drug) $13.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Shelbyville
Dr. Rachel Mitchell, Md, MD
Internal Medicine — Payments: $8,112
Stina Wedlock, Md, MD
Internal Medicine — Payments: $4,544
Nancy Miles, Md, MD
Internal Medicine — Payments: $1,267
Dr. Karim Jacob, Md, MD
Internal Medicine — Payments: $1,085
Dr. Amandeep Aulakh, M.d, M.D
Internal Medicine — Payments: $678.83
Thomas Nedumthottathil, M.d, M.D
Internal Medicine — Payments: $213.22